Antonio Durando

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1

Biyun Qian, Dionyssios Katsaros, Lingeng Lu et al. · Breast Cancer Research and Treatment · 2008 · 258 citations

Tumor Biology, Breast Oncology, Oncology +10

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Lucia Del Mastro, Sabino De Placido, Paolo Bruzzi et al. · The Lancet · 2015 · 196 citations

Breast Oncology, Medicine, Dose-dense Chemotherapy +6

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

Isabella Castellano, Elena Allìa, Valeria Accortanzo et al. · Breast Cancer Research and Treatment · 2010 · 192 citations · Full text

Significant Prognostic Factor, Breast Oncology, Medicine +8

Outcome of Patients with HER2-Positive Advanced Breast Cancer Progressing During Trastuzumab-Based Therapy

Filippo Montemurro, Michela Donadio, Matteo Clavarezza et al. · The Oncologist · 2006 · 128 citations · Full text

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial

Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni et al. · The Lancet Oncology · 2021 · 82 citations

Breast Oncology, Oncology, Postmenopausal Patients +9